Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 110 of the 115 references it cites were found in a registry or an index; 22 of the 65 sources its claims cite were checked for support.
Abstract
Insulin resistance is a characteristic feature of type 2 diabetes and plays a major role in the pathogenesis of the disease (1,2). Although �-cell failure is the sine qua non for development of type 2 diabetes, skeletal muscle insulin resistance is considered to be the initiating or primary defect that is evident decades before �-cell failure and overt hyperglycemia develops (3,4). Insulin resistance is defined as a reduced response of target tissues (compared with subjects with normal glucose tolerance [NGT] without a family history of diabetes), such as the skeletal muscle, liver, and adipocytes, to
Overview
CoChat Summary
TL;DR
This review argues that skeletal muscle insulin resistance—especially impaired glycogen synthesis—is the initiating/primary defect in most type 2 diabetes, preceding β-cell failure and overt hyperglycemia. It concludes that overt diabetes requires β-cell failure to supervene, while muscle insulin resistance is already evident in normal glucose-tolerant high-risk relatives and prospective populations.
Key findings
- Skeletal muscle is the predominant site of insulin-mediated postprandial glucose uptake: under euglycemic hyperinsulinemia, ∼80% of glucose uptake occurs in skeletal muscle; leg muscle glucose uptake plateaus at ∼10 mg/kg leg weight per minute after 60 min, and in lean type 2 diabetic subjects it is reduced by ∼50% during the last hour of the insulin clamp.
- In lean NGT offspring of two type 2 diabetic parents, a two-step euglycemic clamp (20 and 40 mU/m² per min; plasma insulin ∼40 and ∼80 μU/ml) showed glucose uptake decreased by 33% and 43%, respectively; the impairment was accounted for entirely by reduced nonoxidative glucose metabolism/glycogen synthesis, with no defect in insulin suppression of hepatic glucose production.
- Prospective Pima Indian data showed both progressors and nonprogressors had a further 11–14% reduction in insulin sensitivity; nonprogressors increased insulin secretion by 30%, whereas progression to type 2 diabetes was associated with a 78% decline in the acute insulin response to intravenous glucose.
- Hyperinsulinemia itself worsens muscle insulin resistance: a 72 pmol/l (11 μU/ml) increase in plasma insulin for 72–96 h reduced insulin-stimulated glucose disposal by 30–40%, entirely via impaired nonoxidative glucose disposal; in rats, 7-day hyperinsulinemia reduced total-body glucose uptake, storage, and glycolysis by 39%, 62%, and 26%. Mitochondrial ATP production increased by 90% in NGT subjects without family history but only 5% in insulin-resistant offspring.
Methods
- Narrative review/symposium article; no primary study design or new sample. It synthesizes human studies using the euglycemic insulin clamp (described as the gold standard), indirect calorimetry, muscle biopsy, femoral/forearm catheterization, PET, NMR spectroscopy, OGTT, and prospective follow-up.
- Populations discussed include lean NGT first-degree relatives/offspring of two type 2 diabetic parents, Mexican Americans, Pima Indians, Caucasians in San Antonio, and type 2 diabetic subjects. Main analysis is qualitative synthesis of cited evidence.
Limitations
- Stated: by the time hyperglycemia is manifest, multiple abnormalities (elevated glucose, FFA, and cytokines) coexist, making it extremely difficult to separate each defect’s contribution; at initial presentation it is not possible to define which defect came first.
- Stated: it is unclear whether mitochondrial dysfunction leads to increased intramyocellular lipid and insulin resistance or increased muscle lipid leads to mitochondrial dysfunction and insulin resistance (“which is the cart and which is the horse”).
- Evident: as a narrative review, it lacks systematic search, formal quality assessment, or meta-analysis; conclusions depend on selected cited studies, and several figures are in an online appendix rather than the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 22 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In type 2 diabetes, impaired glycogen synthesis secondary to reduced glycogen synthase activity is the earliest detectable metabolic defect ( 39 – 41 ).”
What the sources say
- Not matchedcites [39] DeFronzo, 1997, Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying genes, Diabetes Rev
We searched by its title and found no matching paper.
- Partly supportedcites [40] Bogardus, 1984, Correlation between muscle glycogen synthase activity and in vivo insulin action in man, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports a correlation between muscle glycogen synthase activity and insulin-mediated glucose storage in glucose-tolerant and diabetic subjects. It hypothesizes a link between reduced enzyme activity and impaired glucose handling, but does not establish that one causes the other or that impaired glycogen synthesis is the earliest detectable metabolic defect in type 2 diabetes. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [41] Shulman, 1990, Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy, N Engl J Med source
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Maintaining the integrity of the IRS-1/PI-3 kinase/Akt pathway is essential for normal insulin-mediated glucose uptake in skeletal muscle ( 26 ).”
What the sources say
- Partly supportedcites [26] Krook, 2000, Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients, Diabetes sourceExperimental — accuracy not yet measured
The paper’s introduction identifies IRS-1 and PI 3-kinase as components of insulin signaling involved in skeletal-muscle glucose transport. Its study summary says reduced PI 3-kinase activity may partly account for reduced insulin-stimulated glucose transport, while additional defects contribute. The cited passages do not establish a role for Akt or show that integrity of the entire pathway is essential for normal uptake. (LLM, conf=0.88)
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Multiple investigators unequivocally have demonstrated that lean NGT offspring of two parents with type 2 diabetes exhibit moderate to severe skeletal muscle insulin resistance ( 28 – 33 ).”
What the sources say
- Not checked — no full text of the sourcecites [28] Perseghin, 1997, Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study, Diabetes source
- Not checked — no full text of the sourcecites [29] Ferrannini, 2003, Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis, J Clin Endocrinol Metab source
- Not checked — no full text of the sourcecites [30] Kashyap, 2004, Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes, Am J Physiol Endocrinol Metab source
- Partly supportedcites [31] Vaag, 1992, Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus, J Clin Invest sourceExperimental — accuracy not yet measured
The Subjects section says the participants were nonobese, had normal oral glucose tolerance, and had at least one parent with NIDDM—not necessarily two. The Discussion reports skeletal-muscle insulin resistance but also considerable overlap with controls; it does not establish moderate-to-severe resistance in offspring of two affected parents. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [32] Gulli, 1992, The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents, Diabetes source
- Not checked — no full text of the sourcecites [33] Tripathy, 2003, Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband, Am J Physiol source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In lean insulin-resistant NGT offspring of type 2 diabetic parents, increased serine phosphorylation of IRS-1 in skeletal muscle has been documented in association with impaired activation of Akt ( 57 ) (Fig. A11).”
What the sources say
- Supportedcites [57] Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest source
The Introduction describes the offspring as young, lean, normoglycemic, and insulin-resistant. The Results report increased IRS-1 serine phosphorylation and reduced insulin-stimulated Akt phosphorylation in the offspring, and the Discussion explicitly describes these findings as associated. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This observation is of important clinical significance, since diacylglycerol, long-chain fatty acyl CoAs, and ceramides all have been shown to cause serine phosphorylation of insulin resistance and IRS-1 and lead to the development of insulin resistance in skeletal muscle ( 59 , 60 ).”
What the sources say
- Not checked — no full text of the sourcecites [59] Hotamisligil, 1996, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance, Science source
- Partly supportedcites [60] Jiang, 1999, Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion says elevated free fatty acids may impair insulin’s metabolic action and notes protein kinase C activation in skeletal muscle. It does not say that diacylglycerol, long-chain fatty acyl CoAs, or ceramides cause IRS-1 serine phosphorylation and thereby produce skeletal-muscle insulin resistance; its serine-phosphorylation discussion concerns the insulin receptor instead. Page numbers are unavailable in our copy. (LLM, conf=0.83)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims · 6 with their cited sources checked
Create a free account to see all 48 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 4
- It may state two separate claims as one. 20
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various epidemiological and experimental studies have shown that muscle weakness, decreased muscle mass, reduced activation of glycogen synthase, and alterations in the numbers of glycolytic skeletal muscle fibers are related to, and may precede, insulin resistance, glucose intolerance, and T2D [332,333].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [333]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even though pancreatic beta cell dysfunction is the main pathogenesis of type 2 diabetes mellitus, given that the uptake of postprandial glucose by skeletal muscles is approximately 80–90%, skeletal muscle IR plays a crucial role in the development and progression of diabetes mellitus [129,130].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dysregulation of these processes contributes to the pathogenesis of numerous diseases, including diabetes and obesity (DeFronzo and Tripathy, 2009; Sugden et al., 2009), mitochondrial disorders (Kerr, 2013), cardiac failure (Fillmore and Lopaschuk, 2013), neurodegenerative disorders (Cunnane et al., 2011; Yao et al., 2011), and cancer (Currie et al., 2013; Tennant et al., 2010).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as DeFronzo and Tripathy, 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the SM accounts for >80% of glucose uptake in the post-prandial period following an oral glucose load, with linear increases in uptake over time [17,20].”
From Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Skeletal muscle is the main tissue responsible for insulin-stimulated glucose disposal and an impaired uptake is common in obesity and has substantial impact on whole-body glucose turnover.8,9”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“RESEARCH DESIGN AND METHODS — The euglycemic insulin clamp technique (5) is considered to be the gold standard for measuring insulin action in vivo.”
BackgroundSelf-citationMatsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“70) with insulin sensitivity measured with the euglycemic insulin clamp (9).”
MethodSelf-citationKatz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“This results in activation of downstream protein kinase B (also called Akt) and phosphorylation of Akt substrate 160 (AS160), which facilitates the translocation of GLUT4 to the sarcolemma and subsequent entry of glucose into the cell (25).”
BackgroundHotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · cited 7×
“Because the majority of type 2 diabetic subjects are obese, they also have daylong elevation of the plasma free fatty acid (FFA) concentration and increased circulating levels of inflammatory cytokines (1,2).”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 2
- Pendergrass, 2007, Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals, Am J Physiol Endocrinol Metab, 292, E92, 10.1152/ajpendo.00617.2005 · DOI · Paper page
- Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest, 115, 3587, 10.1172/jci25151 · DOI · Paper page
Cited by
Items 801–900 of 2,099
Prioritizing movement to address the frailty phenotype in heart failure
Laddu, D., Ozemek, C., Sabbahi, A., Severin, R. S., Phillips, S. A., & Arena, R. A. (2021) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2021.01.005 · Cited by 21
Circadian misalignment disturbs the skeletal muscle lipidome in healthy young men
Harmsen, J., van Polanen, N., van Weeghel, M., Wefers, J., Hoeks, J., Vaz, F. M., Pras‐Raves, M. L., van Kampen, A. H. C., Schaart, G., van Moorsel, D., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202100143r · Cited by 21
Segerström, Å. B., Elgzyri, T., Eriksson, K., Groop, L., Thorsson, O., & Wollmer, P. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.05.022 · Cited by 25
“[23] DeFronzo RA, Tripathy D.”
ResultDapper1 attenuates hepatic gluconeogenesis and lipogenesis by activating PI3K/Akt signaling
Kuang, J.-R., Zhang, Z., Leng, W., Lei, X., & Liang, Z. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.028 · Cited by 20
Inhibition of C1-Ten PTPase activity reduces insulin resistance through IRS-1 and AMPK pathways
Jeong, H., Koh, A., Lee, J., Park, D., Lee, J. O., Lee, M. N., Jo, K.-J., Tran, H. N. K., Kim, E., Min, B.-S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-18081-8 · Cited by 20
de Lucena, D. D., de Sá, J. R., Pestana, J. O. M., & Rangel, É. B. (2020) · Journal of Diabetes Research · doi:10.1155/2020/1938703 · Cited by 22
Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management
Barber, T. M., Kabisch, S., Pfeiffer, A. F. H., & Weickert, M. O. (2025) · Metabolites · doi:10.3390/metabo15020085 · Cited by 19
“Furthermore, the SM accounts for >80% of glucose uptake in the post-prandial period following an oral glucose load, with linear increases in uptake over time [17,20].”
Marcella, B. M., Hockey, B. L., Braun, J. L., Whitley, K. C., Geromella, M. S., Baranowski, R. W., Watson, C. J. F., Silvera, S., Hamstra, S. I., Wasilewicz, L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53886-y · Cited by 26
“We thank the reviewer for their time and positive comments in support of our study.”
Goto, H., & Takamura, T. (2025) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes25017 · Cited by 30
“50,51 Moreover, observational studies have shown that glycogen synthesis in skeletal muscle is reduced in elderly individuals, compared with younger ones, whereas hepatic de novo lipogenesis is enhanced.”
Practical combination therapy based on pathophysiology of type 2 diabetes
LEVIN, P. A. (2016) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s109216 · Cited by 22
“2,22 The overall extent to which β -cell function is impaired determines the severity of hyperglycemia, and the progressive failure of β -cells accounts for the transition from impaired glucose tolerance to T2D.”
InfluentialTherapeutic approaches to diabetic cardiomyopathy: Targeting the antioxidant pathway
Arad, M., Waldman, M., Abraham, N. G., & Hochhauser, E. (2020) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2020.106454 · Cited by 21
Metabolomics reveal circadian control of cellular metabolism
Ch, R., Chevallier, O. P., & Elliott, C. T. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.115986 · Cited by 22
Duranti, G., Maldini, M., Crognale, D., Sabatini, S., Corana, F., Horner, K. M., & Ceci, R. (2020) · Phytomedicine Plus · doi:10.1016/j.phyplu.2020.100014 · Cited by 25
Sarcopenia: An Age-Related Multifactorial Disorder
Priyadarsini, N., Nanda, P., Devi, S., & Mohapatra, S. (2022) · Current Aging Science · doi:10.2174/1874609815666220304194539 · Cited by 23
Brunetta, H. S., Petrick, H. L., Momken, I., Handy, R. M., Pignanelli, C., Nunes, E. A., Piquereau, J., Mericskay, M., & Holloway, G. P. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102307 · Cited by 20
“Considered as the major site for insulin-stimulated glucose uptake, skeletal muscle plays a fundamental role in the maintenance of whole-body glucose and fatty acid homeostasis [13,23].”
BackgroundHartanti, D., Chatsumpun, N., Kitphati, W., Peungvicha, P., & Supharattanasitthi, W. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14018 · Cited by 29
“Skeletal muscle plays a crucial role in postprandial glucose control and is one of the main target sites for insulin action [18].”
BackgroundElectrical impedance myography detects age-related skeletal muscle atrophy in adult zebrafish
Rutkove, S. B., Callegari, S., Concepcion, H. A., Mourey, T., Widrick, J. J., Nagy, J. A., & Nath, A. K. (2023) · Scientific Reports · doi:10.1038/s41598-023-34119-6 · Cited by 23
Mechanism of immune attack in the progression of obesity-related type 2 diabetes
Wang, H., Tang, J., Sun, L., Li, Z., Deng, M., & Dai, Z. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i5.494 · Cited by 22
Ren, Y., Li, Z., Li, J., Liang, R., Wang, Z., Bai, Y., Yang, Y., Tang, Q., Fu, Y., Zhang, X., et al. (2023) · Obesity Reviews · doi:10.1111/obr.13639 · Cited by 27
Metabolomics and mitochondrial dysfunction in cardiometabolic disease
Shastry, A., & Dunham‐Snary, K. J. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122137 · Cited by 24
Ahmad, K., Shaikh, S., Lim, J. H., Ahmad, S. S., Chun, H. J., Lee, E. J., & Choi, I. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115642 · Cited by 28
Adipose Tissue, Non-Communicable Diseases, and Physical Exercise: An Imperfect Triangle
Monsalve, F. A., González, D. R., Fernández-Tapia, B., & López, F. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417168 · Cited by 21
“…by altering the PI3K signaling pathway in muscle, inducing the expression of gluconeogenic enzymes and the oxidation of fatty acids in the liver, giving liver and muscle IR as a final result, causing abnormal glucose production from the liver [67] and reduced glucose uptake by skeletal muscle [68].”
BackgroundPirani, H., Soltany, A., Rezaei, M. H., Fard, A. K., Nikooie, R., Khoramipoor, K., Chamari, K., & Khoramipour, K. (2024) · Scientific Reports · doi:10.1038/s41598-023-50589-0 · Cited by 23
“IR of skeletal muscle could lead to T2D 27 .”
BackgroundEffect of Weight Loss on Skeletal Muscle Bioactive Lipids in People With Obesity and Type 2 Diabetes
Petersen, M. C., Yoshino, M., Smith, G. I., Gaspar, R. C., Kahn, M., Samovski, D., Shulman, G. I., & Klein, S. (2024) · Diabetes · doi:10.2337/db24-0083 · Cited by 23
Scriptaid enhances skeletal muscle insulin action and cardiac function in obese mice
Gaur, V., Connor, T., Venardos, K. M., Henstridge, D. C., Martin, S. D., Swinton, C., Morrison, S., Aston‐Mourney, K., Gehrig, S. M., van Ewijk, R., et al. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12896 · Cited by 18
“impact on aspects of systemic metabolism.(1) First-line pharmacological interventions used to treat metabolic diseases have only limited direct effects on normalizing skeletal muscle metabolism.”
BackgroundGuénard, F., Tchernof, A., Deshaies, Y., Biron, S., Lescelleur, O., Biertho, L. D., Marceau, S., Përusse, L., & Vohl, M. (2017) · Translational research · doi:10.1016/j.trsl.2017.01.002 · Cited by 19
Méndez-García, L. A., Trejo‐Millán, F., Martínez‐Reyes, C. P., Manjarrez‐Reyna, A. N., Esquivel‐Velázquez, M., Meléndez, G., Islas‐Andrade, S., Rojas‐Bernabé, A., Kzhyshkowska, J. G., & Escobedo, G. (2018) · Scandinavian Journal of Immunology · doi:10.1111/sji.12716 · Cited by 24
“Insulin resistance is the inability of skeletal muscle, liver and adipose tissue to respond to normal levels of insulin that results in alteration of glucose homeostasis.(1) In normal conditions, insulin binds to IR and orchestrates phosphorylation of the IRS protein family.”
BackgroundKandhare, A. D., Bandyopadhyay, D., & Thakurdesai, P. A. (2018) · RSC Advances · doi:10.1039/c8ra05204b · Cited by 24
The Crossroads of Aging: An Intersection of Malnutrition, Frailty, and Sarcopenia
Severin, R., Berner, P. M., Miller, K. L., & Mey, J. (2019) · Topics in Geriatric Rehabilitation · doi:10.1097/tgr.0000000000000218 · Cited by 19
Mendelian Randomization Study: The Association Between Metabolic Pathways and Colorectal Cancer Risk
Jung, S. Y., Papp, J. C., Sobel, E. M., & Zhang, Z. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01005 · Cited by 20
“In contrast, 2-h glucose levels reflect beta cell function and insulin sensitivity in skeletal muscle (31), which may represent relatively long-term exposure to IR.”
BackgroundMeister, J., Wang, L., Pydi, S. P., & Wess, J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15314 · Cited by 22
“For this reason, drugs capable of improving impaired β- cell function have great clinical potential for the management of T2D (Hudish et al., 2019; Roden & Shulman, 2019).”
BackgroundInfluentialFujimoto, B., Young, M., Nakamura, N., Ha, H. Y., CARTER, L. T., Pitts, M. W., Torres, D. J., Noh, H. L., Suk, S., Kim, J. K., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100482 · Cited by 20
“In healthy individuals, skeletal muscle takes up 80 to 90% of glucose in response to insulin, and one of the earliest detectable signs of insulin resistance preceding type 2 diabetes (T2D) is reduced insulin-stimulated glucose uptake in skeletal muscle (1).”
BackgroundAnsari, P., Flatt, P. R., Harriott, P., & Abdel‐Wahab, Y. H. A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264632 · Cited by 24
“Obesity, decreased GLUT4 translocation or impairments in signal transduction of muscle and other target cells can cause cellular insulin resistance so agents that promote glucose uptake are desirable as antidiabetic drugs [38, 39].”
BackgroundKim, J. Y., Choi, B. G., Jung, M. J., Wee, J., Chung, K. H., & Kwon, O. (2011) · Journal of the Korean Society for Applied Biological Chemistry · doi:10.3839/jksabc.2011.092 · Cited by 19
“High FFAs impair the capability of insulin to suppress hepatic glucose output and to stimulate glucose uptake into skeletal muscle [Kahn and Flier, 2000; Hotamisligil 2006; Bilan et al., 2009; DeFronzo and Tripathy, 2009].”
BackgroundFanning, K. M., Pfisterer, B. R., Davis, A., Presley, T. D., Williams, I. M., Wasserman, D. H., Cline, J. M., & Kavanagh, K. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00108.2017 · Cited by 23
“The hallmark of metabolic decline and T2DM is peripheral insulin resistance in tissues such as skeletal muscle, which is responsible for the vast majority of insulin-stimulated peripheral glucose metabolism (7).”
BackgroundEffect of baicalin on GLUT4 expression and glucose uptake in myotubes of rats
Fang, P., Yu, M., Wen, M., Wan, D., Han, S., Shan, Y., Wang, R., Shi, M., Zhang, Z., & Bo, P. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.01.022 · Cited by 19
Wewalka, M., Drolz, A., Seeland, B., Schneeweiss‐Gleixner, M., Schmid, M., Schneeweiß, B., & Zauner, C. (2018) · European Journal of Clinical Nutrition · doi:10.1038/s41430-018-0111-4 · Cited by 21
“A limitation of our study is that insulin resistance was not measured using the hyperinsulinemic clamp technique, which is considered the gold standard [26] and that the investigators were not blinded with regard to the nutrition formula.”
MethodSex differences in skeletal muscle metabolism in exercise and type 2 diabetes mellitus
MacGregor, K. A., Ellefsen, S., Pillon, N. J., Hammarström, D., & Krook, A. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01058-9 · Cited by 29
“Impairment in skeletal muscle response to insulin, and thus reduced glucose uptake, is a primary factor in the development of type 2 diabetes mellitus (T2DM) 7 .”
Effects of chronic dexamethasone administration on hyperglycemia and insulin release in goats
Niu, L., Qu, C., Hua, C., Geng, Y., Cai, L., Tao, S., Ni, Y., & Zhao, R. (2018) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-018-0242-4 · Cited by 22
“Glucocorticoids inhibit glucose utilization by reducing both glucose uptake and oxidation in skeletal muscle and white adipose tissue, two major tissues involved in insulinresponsive glucose uptake [32, 33].”
Metabolic‐vascular coupling in skeletal muscle: A potential role for capillary pericytes?
Attrill, E., RAMSAY, C. D., Ross, R. M., Richards, S. M., Sutherland, B. A., Keske, M. A., Eringa, E. C., & Premilovac, D. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13208 · Cited by 20
Islam, M. T., Henson, G. D., Machin, D. R., Bramwell, R. C., Donato, A. J., & Lesniewski, L. A. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111126 · Cited by 18
A mathematical model of food intake
Chudtong, M., Gaetano, A. D., Consiglio Nazionale delle Ricerche, I. P. L. R. E. L. B. (.-I., & Consiglio Nazionale delle Ricerche, I. D. A. D. S. E. I. ". R. (.-I. (2021) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2021067 · Cited by 21
Potential Roles of Endoplasmic Reticulum Stress and Cellular Proteins Implicated in Diabesity
Mustapha, S., Mohammed, M., Azemi, A. K., Yunusa, I. U., Shehu, A., Mustapha, L., Wada, Y., Ahmad, M. H., Ahmad, W. A. N. W., Rasool, A. H. G., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8830880 · Cited by 20
Blackwood, S. J., Horwath, O., Moberg, M., Pontén, M., Apró, W., Ekblom, M., Larsen, F. J., & Katz, A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac221 · Cited by 18
Calderón-DuPont, D., Torre-Villalvazo, I., & Díaz‐Villaseñor, A. (2022) · Biochimie · doi:10.1016/j.biochi.2022.08.021 · Cited by 25
New Horizons: Emerging Antidiabetic Medications
Mingrone, G., Castagneto‐Gissey, L., & Bornstein, S. R. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac499 · Cited by 22
“A finding supporting this paradigm is the preserved insulin 1 secretory capacity of the endocrine pancreas observed in the presence of T2D, particularly in subjects 2 with associated obesity, as compared with individuals with normal insulin sensitivity (16-17).”
BackgroundPrasopthum, A., Insawek, T., & Pouyfung, P. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e10790 · Cited by 29
“This results in hyperglycemia and complications, such as neuropathy, age-related macular degeneration, nephropathy, coronary artery disease, and diabetic foot [3, 4].”
BackgroundLee, M. J., Khang, A. R., Yi, D., & Kang, Y. H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275746 · Cited by 28
“Insulin resistance in the skeletal muscle has important implications in the pathogenesis of type 2 DM and metabolic syndrome [3].”
BackgroundKang, S., Lee, A. G., Im, S., Oh, S. J., Yoon, H. J., Park, J. H., & Pak, Y. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314871 · Cited by 19
“Therefore, considering that most of the glucose obtained from food intake is absorbed by the muscles and liver, and only 5% is taken by adipose tissue [57], and as HBU651 did not change fasting glucose (Figure 3G), the effects of HBU651 may be associated with an improvement of lipid and glucose utilization in the live…”
BackgroundAsprosin: its function as a novel endocrine factor in metabolic-related diseases
Zhang, Y., Yang, P., Zhang, X., Liu, S., & Lou, K. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02360-z · Cited by 24
“Skeletal muscle plays a pivotal role among peripheral organs in insulin action, and the development of skeletal muscle insulin resistance significantly contributes to the pathogenesis of diabetes and metabolic syndrome [96, 97].”
Pharmacology of Hydrogen Sulfide and Its Donors in Cardiometabolic Diseases
Sun, H., Lu, Q.-B., Zhu, X., Ni, Z.-R., Su, J., Fu, X., Guo, C., Zheng, G.-L., Nie, X.-W., & Bian, J. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.000928 · Cited by 23
Chen, C., Chen, Y., Zhai, H., Xiao, Y., Xu, J., Gu, Y., Han, X., Wang, C., Chen, Q., & Lu, H. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116954 · Cited by 20
Mølsted, S., Johnsen, N. F., & Snorgaard, O. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.05.009 · Cited by 19
“A low PA level is a main contributor to the development of T2DM [15] and even after being diagnosed with T2DM, it may be difficult for patients to increase their level of leisure time PA comparable to the level observed among participants without diabetes.”
BackgroundInfluentialCheng, J., Tan, Y., Zhou, J., Xiao, L., Johnson, M. S., & Qu, X. (2020) · Clinical Science · doi:10.1042/cs20200107 · Cited by 19
Renton, M. C., McGee, S. L., & Howlett, K. F. (2020) · Obesity Reviews · doi:10.1111/obr.13145 · Cited by 18
“Skeletal muscle is responsible for 80% of whole-body insulin-stimulated glucose disposal under hyperinsulinaemic-euglycaemic conditions in healthy individuals.(73)”
BackgroundIntracellular pH Regulation of Skeletal Muscle in the Milieu of Insulin Signaling
Posa, D. K., & Baba, S. P. (2020) · Nutrients · doi:10.3390/nu12102910 · Cited by 20
“obesity-associated insulin resistance [4,5].”
Guo, S., Ouyang, H., Du, W., et al. (2021) · Food & Function · doi:10.1039/d0fo01188f · Cited by 18
Sergi, D., Luscombe‐Marsh, N. D., Heilbronn, L. K., Birch‐Machin, M. A., Naumovski, N., Lionetti, L., Proud, C. G., Abeywardena, M. Y., & O’Callaghan, N. J. (2020) · Journal of Nutrition · doi:10.1093/jn/nxaa430 · Cited by 19
Xu, B., Liu, C., Zhang, H., Zhang, R., Tang, M., Huang, Y., Li, J., Xu, L., Hu, C., & Jia, W. (2021) · JCI Insight · doi:10.1172/jci.insight.149969 · Cited by 22
“A growing body of evidence indicates that insulin resistance in skeletal muscles is strongly associated with several metabolic syndromes and T2DM (7, 8).”
Mthembu, S. X. H., Muller, C. J. F., Dludla, P. V., Madoroba, E., Kappo, A. P., & Mazibuko-Mbeje, S. E. (2021) · Molecules · doi:10.3390/molecules26206289 · Cited by 24
“Here, treating skeletal muscle cells with aspalathin, isoorientin, orientin greatly improved mitochondrial basal respiration, maximal respiration, and spare capacity following exposure to antimycin A. Notably, from the literature, the decrease in mitochondrial oxidative capacity has been linked to the reduced ATP synt…”
BackgroundInfluentialProfiling of human myotubes reveals an intrinsic proteomic signature associated with type 2 diabetes
Al‐Khalili, L., Barbosa, T. D. C., Östling, J., Massart, J., Katayama, M., Nyström, A., Oscarsson, J., & Zierath, J. R. (2013) · Translational Proteomics · doi:10.1016/j.trprot.2013.12.002 · Cited by 19
“80% of insulin-stimulated glucose uptake, and impairments in insulin action on non-oxidative glucose metabolism in this tissue are among the earliest metabolic defects in T2D [4].”
Shrivastava, S. K., Batham, A., Sinha, S. K., Parida, T. K., Garabadu, D., & Choubey, P. K. (2016) · Medicinal Chemistry Research · doi:10.1007/s00044-016-1675-y · Cited by 23
The Obesity–Impulsivity Axis: Potential Metabolic Interventions in Chronic Psychiatric Patients
Sfera, A., Osorio, C. P., Inderias, L., Parker, V., Price, A. I., & Cummings, M. A. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00020 · Cited by 20
Liu, H., Chan, Y., Wei, C.-C., Chen, Y.-A., Wang, M.-F., & Chang, S.-J. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.08.023 · Cited by 22
“Skeletal muscle is the major peripheral tissue responsible for insulin-mediated glucose uptake (DeFronzo and Tripathy, 2009).”
BackgroundHsu, M.-C., Wang, M., Jiang, Y.-F., Liu, H., Chen, Y., & Chiu, C. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0281-6 · Cited by 18
“This evidence also supports the idea that insulin resistance in skeletal muscle rather than liver is the preliminary defect in the development of metabolism syndrome and type 2 diabetes [9, 30].”
Vernonia cinerea water extract improves insulin resistance in high-fat diet–induced obese mice
Naowaboot, J., Wannasiri, S., & Pannangpetch, P. (2018) · Nutrition Research · doi:10.1016/j.nutres.2018.04.020 · Cited by 21
Montero, D., Oberholzer, L., Haider, T., Andersen, A. B., Dandanell, S., Meinild‐Lundby, A., Maconochie, H., & Lundby, C. (2018) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2018-0195 · Cited by 21
Annona stenophylla aqueous extract stimulate glucose uptake in established C2Cl2 muscle cell lines
Taderera, T., Chagonda, L. S., Gomo, E., Katerere, D. R., & Shai, L. J. (2019) · African Health Sciences · doi:10.4314/ahs.v19i2.47 · Cited by 18
Mitochondrial function assessed by 31P MRS and BOLD MRI in non‐obese type 2 diabetic rats
Liu, Y., Mei, X., Li, J., Lai, N., & Yu, X. (2016) · Physiological Reports · doi:10.14814/phy2.12890 · Cited by 17
“Correspondence Xin Yu, Sc.D., Department of Biomedical Engineering, Case Western Reserve University, Wickenden 430, 10900 Euclid Avenue, Cleveland, OH 44106.”
BackgroundIslam, M. T., Cai, J., Allen, S., Moreno, D. G., Bloom, S. I., Bramwell, R. C., Mitton, J., Horn, A. G., Zhu, W., Donato, A. J., et al. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.319375 · Cited by 18
“1–4 One such mechanism of insulin resistance that has been described in both obesity and advancing age is adipose tissue dysfunction.”
BackgroundAre we giving too much weight to lean mass loss?
Bolte, J., Smelter, A. A., & Norton, L. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102253 · Cited by 22
“Insulin resistance is defined as a decreased glucose infusion rate required to maintain normoglycemia during a euglycemic insulin clamp [20].”
Immunometabolism in type 2 diabetes mellitus: tissue-specific interactions
Pinheiro-Machado, E., Gurgul-Convey, E., & Marzec, M. (2020) · Archives of Medical Science · doi:10.5114/aoms.2020.92674 · Cited by 27
“The skeletal muscle (SM) is the primary site for dietary glucose uptake and storage in the form of glycogen, being, consequently, a crucial component affected during the development of insulin resistance [6].”
BackgroundRemchak, M. E., Piersol, K. L., Bhatti, S., Spaeth, A. M., Buckman, J. F., & Malin, S. K. (2021) · Nutrients · doi:10.3390/nu13051708 · Cited by 21
Vasyukova, O. V., Kasyanova, Y. V., Okorokov, P. L., & Bezlepkina, O. B. (2021) · Problems of Endocrinology · doi:10.14341/probl12779 · Cited by 20
Lim, S., Deaver, J. W., Rosa‐Caldwell, M. E., Lee, D. E., da Silva, F. M., Cabrera, A. R., Schrems, E. R., Saling, L. W., Washington, T. A., Fluckey, J. D., et al. (2022) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00333.2021 · Cited by 21
Insulin resistance corresponds with a progressive increase in NOD1 in high fat diet-fed mice
Sharma, A., Singh, S., Mishra, A., Rai, A. K., Ahmad, I., Ahmad, S., Gulzar, F., Schertzer, J. D., Shrivastava, A., & Tamrakar, A. K. (2022) · Endocrine · doi:10.1007/s12020-022-02995-z · Cited by 17
“We also confirmed that HFD feeding induced insulin intolerance associated with decreased insulin signaling in skeletal muscle and liver, which are insulin sensitive tissues, responsible for the maintenance of glucose homeostasis [47].”
BackgroundChronic Elevation of Skeletal Muscle [Ca2+]i Impairs Glucose Uptake. An in Vivo and in Vitro Study
Uryash, A., Mijares, A., Lopez, C. E., Adams, J. A., & Lopez, J. R. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.872624 · Cited by 18
Sharma, A., Lee-Ødegård, S., Qvigstad, E., Sommer, C., Sattar, N. A., Gill, J. M. R., Gulseth, H. L., Sollid, S. T., Nermoen, I., & Birkeland, K. I. (2022) · Diabetes · doi:10.2337/db22-0622 · Cited by 25
Cheng, J., Ma, X., Yan, G., Yu, Q., Huang, Z., Lin, G., Li, M., Guan, F., Su, Z., Yan, F., et al. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.113731 · Cited by 18
Skeletal Muscle Consequences of Phosphatidylethanolamine Synthesis Deficiency
Grapentine, S., Singh, R. K., & Bakovic, M. (2023) · Function · doi:10.1093/function/zqad020 · Cited by 22
“10 11–13 Myosteatosis has been shown as both a precursor and a propagator of skeletal muscle insulin resistance and impaired muscle function, and its association with perturbations in the muscle secretome is believed to promote inflammation and hepatocellular injury, directly linking it to…”
Jevtovic, F., Zheng, D., Houmard, J. A., Kern, K., Claiborne, A., Lopez, C. A., Broskey, N. T., Isler, C. M., DeVente, J., Newton, E. R., et al. (2023) · Obesity · doi:10.1002/oby.23829 · Cited by 19
“Considering that skeletal muscle is responsible for approximately 80% of insulin-stimulated glucose uptake, impaired skeletal muscle insulin action is an integral component of the pathophysiology of these metabolic disorders and it contributes significantly to systemic IR [3].”
BackgroundResveratrol as a potential protective compound against skeletal muscle insulin resistance
Bahramzadeh, A., Bolandnazar, K., & Meshkani, R. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21305 · Cited by 19
“Any skeletal muscle dysfunction affects glucose homeostasis in the whole body and leads to impaired glucose tolerance and type 2 diabetes [7 – 9] Pharmacological and non-pharmacological treatment strategies have the potential to improve insulin sensitivity and increase the chances of survival in…”
BackgroundHuang, W., Deng, S., Liu, S. M., Ma, Q., Cao, L., Liu, L., Wan, H., & Shen, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1346669 · Cited by 22
Lu, J., Tang, Z., Xu, M., Lu, J., Wang, F., Ni, X., Wang, C., & Yu, B. (2024) · Redox Report · doi:10.1080/13510002.2024.2347139 · Cited by 19
“Skeletal muscle IR is implicated as a major cause of T2D [5], involving pathways like mitochondrial dysfunction, inflammation, and oxidative stress [6–8].”
Adewuyi, E. O., Porter, T., O’Brien, E. K., Olaniru, O. E., Verdile, G., & Laws, S. M. (2024) · Communications Biology · doi:10.1038/s42003-024-06333-z · Cited by 18
Association between sarcopenia and sleep disorders: a cross-sectional population based study
Liu, K., Luo, J., Chen, Y., Li, B., Tian, Y., Wang, X., & Liao, X. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1415743 · Cited by 20
“Skeletal muscle plays a crucial role as a primary target for insulin action, and the decline in muscle mass and strength can potentially worsen insulin resistance (30).”
BackgroundZhou, X., Ren, L., Yu, Z., Huang, X., Li, Y., & Wang, C. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.02.023 · Cited by 17
Lorenzo, A. D., Bavel, D. V., de Moraes, R., & Tibiriçá, E. V. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-019304 · Cited by 20
Impaired glucose partitioning in primary myotubes from severely obese women with type 2 diabetes
Zou, K., Turner, K., Zheng, D., Hinkley, J. M., Kugler, B. A., Hornby, P. J., Lenhard, J. M., Jones, T. E., Pories, W. J., Dohm, G. L., et al. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00157.2020 · Cited by 17
Burns, A., Nixon, A., Mallinson, J. E., Cordon, S. M., Stephens, F. B., & Greenhaff, P. L. (2021) · The Journal of Physiology · doi:10.1113/jp281021 · Cited by 19
“As the majority of glucose uptake occurs in skeletal muscle (DeFronzo & Tripathy, 2009), it can be assumed that this blunting effect reflects muscle specific inhibition of glucose uptake.”
BackgroundLiu, L., Zheng, J., Zhou, M., Li, S., He, G., & Wu, J. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c00587 · Cited by 18
Costa, J. S. R., Fonseca, G. F. A. C., Ottone, N. C. D. S., Silva, P. A., Antonaccio, R. F., Silva, G., Rocha, M. D. S. A., Coimbra, C. C., Esteves, E. A., Mang, Z. A., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119639 · Cited by 21
Progression from prediabetes to type 2 diabetes mellitus induced by overnutrition
Zhang, Y., Shen, T., & Wang, S. (2022) · HORMONES · doi:10.1007/s42000-022-00399-2 · Cited by 20
“The prevailing view is that excessive energy intake causes peripheral tissue resistance to insulin and increases the blood glucose concentration, in turn stimulating insulin secretion by β-cells in the islets of Langerhans [9].”
BackgroundRole of skeletal muscle autophagy in high-fat-diet–induced obesity and exercise
Herrenbruck, A. R., & Bollinger, L. M. (2019) · Nutrition Reviews · doi:10.1093/nutrit/nuz044 · Cited by 19
Predictive Accuracy of Surrogate Indices for Hepatic and Skeletal Muscle Insulin Sensitivity
Muniyappa, R., Tella, S. H., Sortur, S., Mszar, R., Grewal, S., Abel, B. S., Auh, S., Chang, D. C., Krakoff, J., & Skarulis, M. C. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2018-00206 · Cited by 16
“Skeletal muscle insulin resistance is characterized by reduced insulinmediated glucose disposal and contributes to postprandial hyperglycemia [7].”
BackgroundBahn, Y. J., Yadav, H., Piaggi, P., Abel, B. S., Gavrilova, O., Springer, D., Papazoglou, I., Zerfas, P. M., Skarulis, M. C., McPherron, A. C., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci162479 · Cited by 22
“Inefficient glucose uptake by insulin-responsive tissues, chiefly skeletal muscle, is a hallmark of T2D pathogenesis (4, 5).”
Qassab, M. A., Chaarani, N., Hamou, A., Harb, R. M., Jradi, A., Zeineddine, M., Ghadieh, H. E., Khattar, Z. A., Azar, S. T., Kanaan, A., et al. (2026) · FASEB BioAdvances · doi:10.1096/fba.2025-00218 · Cited by 31
Kakehi, S., Tamura, Y., Ikeda, S., Kaga, N., Taka, H., Ueno, N., Shiuchi, T., Kubota, A., Sakuraba, K., Kawamori, R., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00254.2020 · Cited by 21
Chattopadhyay, S., Joharapurkar, A. A., Das, N., Khatoon, S., Kushwaha, S., Gurjar, A. A., Singh, A. K., Shree, S., Ahmed, M. Z., China, S. P., et al. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111525 · Cited by 16
Chen, F., Liu, J., Hou, D., Li, T., Chen, Y., Liao, Z., & Wu, L. (2022) · Nutrients · doi:10.3390/nu14112272 · Cited by 24
Metadata
- Authors
- DeFronzo, R. A., & Tripathy, D.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Tripathy, Devjit
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S157-S163
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811436
- OpenAlex
- W2170869159
- Cited by
- 2,102
- References
- 115
- Citations by year
- 2026: 149 · 2025: 188 · 2024: 187 · 2023: 161 · 2022: 200 · 2021: 199 · 2020: 161 · 2019: 146 · 2018: 166 · 2017: 132 · 2016: 119 · 2015: 99 · 2014: 72 · 2013: 54 · 2012: 29
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- skeletal muscle insulin resistance, type 2 diabetes, insulin resistance, beta-cell failure, type 2 diabetes pathogenesis, glucose tolerance, hyperglycemia
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Homeostasis, Humans, Insulin, Insulin Resistance, Glucose Clamp Technique, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.